Ads
related to: safest psoriatic arthritis treatmenthelperwizard.com has been visited by 100K+ users in the past month
assistantcat.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Bimekizumab, sold under the brand name Bimzelx (/ b ɪ m ˈ z ɛ l ɪ k s / bim-ZEL-iks), is a humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody [6] [7] that is used to treat plaque psoriasis, psoriatic arthritis, axial spondyloarthritis, ankylosing spondylitis, and hidradenitis suppurativa.
Risankizumab, sold under the brand name Skyrizi (/ s k aɪ ˈ r ɪ z i / sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. [6] [7] It is designed to target interleukin 23A (IL-23A). [6] [7] [9] It is given by subcutaneous injection. [6] [7]
Psoriatic arthritis is a type of arthritis that develops in some people who have psoriasis, which is a chronic autoimmune disease of the skin. Psoriatic arthritis can be mild or severe. It can ...
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
Which types of arthritis treatment are recommended to you can depend on the kind of arthritis that you have and how severe it is. The overarching goals of arthritis treatment are to: Ease your ...
The Food and Drug Administration (FDA) has approved Johnson & Johnson's psoriatic arthritis treatment Stelara for patients 18 years or older, the company announced Monday. The approved treatment ...
Free health webcasts from leading psoriatic disease experts arm people with information to reduce pain, inflammation, and itching; clear skin; loosen joints; better understand future treatment options; and decrease their risk for related conditions associated with psoriatic diseases like heart disease and diabetes.
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis. [8] [9] [10] It is a janus kinase (JAK) inhibitor, [8] [9] discovered and developed by the National Institutes of ...